FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for mycophenolate mofetil submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)